CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

Moderna said on Friday it had filed a marketing application for an updated COVID vaccine to the U.S. Food and Drug ...

Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared ...

The revised version of the vaccine, marketed as Spikevax, follows FDA guidance recommending that this year’s shots target ...

The FDA will limit the vaccine’s availability later this year to older adults and those who may be at risk of severe illness.

U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...

MODERNA said on Friday it has filed a marketing application for the review of its updated Covid-19 vaccine with the US Food and Drug Administration (FDA).

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

The US Food and Drug Administration has ordered Pfizer and Moderna to expand their warning labels on COVID-19 vaccines.

The FDA picked the LP.8.1 Covid strain for the fall vaccines, fueling concerns that the shots may be limited to only the most ...